Trials / Completed
CompletedNCT01078337
T-cell Minimal Residual Disease (MRD) Evaluation Using Flow Cytometric Analysis
T-cell MRD Evaluation Using Flow Cytometric Analysis
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 15 (estimated)
- Sponsor
- Stanford University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
To determine if MRD (minimal residual disease) can be found in the blood (only) as opposed to bone marrow in children with ALL (acute lymphoblastic leukemia).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | bone marrow aspiration | |
| PROCEDURE | peripheral blood sampling |
Timeline
- Start date
- 2002-11-01
- Primary completion
- 2007-10-01
- Completion
- 2007-10-01
- First posted
- 2010-03-02
- Last updated
- 2010-03-02
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01078337. Inclusion in this directory is not an endorsement.